-transparent.png){kind=logo}
Cyproterone acetate (CPA) is a synthetic steroid which is used in oral contraceptive and anti-androgen formulations. It has previously been classified as a tumor promoter in rat liver. Recent studies have shown that CPA induces DNA repair synthesis in isolated hepatocytes, and this implies that CPA is genotoxic. We studied the initiating activity of CPA in vivo by means of a rat liver foci bioassay, using weanling female Sprague-Dawley rats. The results show that CPA induces adenosine-triphosphatase-deficient and gamma-glutamyltranspeptidase-positive putative preneoplastic foci in a dose-dependent manner. This indicates that CPA has not only promoting but also initiating activity and may therefore act as a complete carcinogen in rat liver.
E Deml, and
L R Schwarz, and
D Oesterle
March 1996,
Carcinogenesis,
E Deml, and
L R Schwarz, and
D Oesterle
October 1995,
Carcinogenesis,
E Deml, and
L R Schwarz, and
D Oesterle
December 1989,
Toxicology letters,
E Deml, and
L R Schwarz, and
D Oesterle
February 1982,
Cancer letters,
E Deml, and
L R Schwarz, and
D Oesterle
May 1986,
Carcinogenesis,
E Deml, and
L R Schwarz, and
D Oesterle
December 1986,
Toxicology and industrial health,
E Deml, and
L R Schwarz, and
D Oesterle
December 1984,
Archives of toxicology,
E Deml, and
L R Schwarz, and
D Oesterle
February 1991,
Hepatology (Baltimore, Md.),
E Deml, and
L R Schwarz, and
D Oesterle
June 1998,
Cancer letters,
E Deml, and
L R Schwarz, and
D Oesterle
November 1986,
Environmental health perspectives,
